搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Haemophilus influenzae Cell division protein FtsQ (ftsQ), partial CSB-YP338054HTA
CSB-EP338054HTA
CSB-BP338054HTA
CSB-MP338054HTA
CSB-EP338054HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Cell division protein FtsA (ftsA) CSB-YP338055HTA
CSB-EP338055HTA
CSB-BP338055HTA
CSB-MP338055HTA
CSB-EP338055HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae UPF0042 nucleotide-binding protein HI_1146 (HI_1146) CSB-YP338056HTA
CSB-EP338056HTA
CSB-BP338056HTA
CSB-MP338056HTA
CSB-EP338056HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Lipopolysaccharide export system ATP-binding protein LptB (lptB) CSB-YP338057HTA
CSB-EP338057HTA
CSB-BP338057HTA
CSB-MP338057HTA
CSB-EP338057HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Lipopolysaccharide export system protein lptC (lptC), partial CSB-YP338058HTA1
CSB-EP338058HTA1
CSB-BP338058HTA1
CSB-MP338058HTA1
CSB-EP338058HTA1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Hypoxanthine phosphoribosyltransferase (hpt) CSB-YP338059HTA
CSB-EP338059HTA
CSB-BP338059HTA
CSB-MP338059HTA
CSB-EP338059HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Anaerobic ribonucleoside-triphosphate reductase-activating protein (nrdG) CSB-YP338060HTA
CSB-EP338060HTA
CSB-BP338060HTA
CSB-MP338060HTA
CSB-EP338060HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae ATP-binding/permease protein CydD (cydD), partial CSB-YP338061HTA1
CSB-EP338061HTA1
CSB-BP338061HTA1
CSB-MP338061HTA1
CSB-EP338061HTA1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Putative esterase HI_1161 (HI_1161) CSB-YP338062HTA
CSB-EP338062HTA
CSB-BP338062HTA
CSB-MP338062HTA
CSB-EP338062HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Protein opa (opa) CSB-YP338063HTA
CSB-EP338063HTA
CSB-BP338063HTA
CSB-MP338063HTA
CSB-EP338063HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Arginine ABC transporter permease protein ArtQ (artQ), partial CSB-YP338064HTA1
CSB-EP338064HTA1
CSB-BP338064HTA1
CSB-MP338064HTA1
CSB-EP338064HTA1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Arginine transport ATP-binding protein ArtP (artP) CSB-YP338065HTA
CSB-EP338065HTA
CSB-BP338065HTA
CSB-MP338065HTA
CSB-EP338065HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Dipeptide transport ATP-binding protein DppF (dppF) CSB-YP338066HTA
CSB-EP338066HTA
CSB-BP338066HTA
CSB-MP338066HTA
CSB-EP338066HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Dipeptide transport ATP-binding protein DppD (dppD) CSB-YP338067HTA
CSB-EP338067HTA
CSB-BP338067HTA
CSB-MP338067HTA
CSB-EP338067HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae 7-carboxy-7-deazaguanine synthase (queE) CSB-YP338068HTA
CSB-EP338068HTA
CSB-BP338068HTA
CSB-MP338068HTA
CSB-EP338068HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Glycine cleavage system transcriptional activator homolog (gcvA) CSB-YP338069HTA
CSB-EP338069HTA
CSB-BP338069HTA
CSB-MP338069HTA
CSB-EP338069HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Succinyl-CoA ligase [ADP-forming] subunit alpha (sucD) CSB-YP338070HTA
CSB-EP338070HTA
CSB-BP338070HTA
CSB-MP338070HTA
CSB-EP338070HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Ribosomal large subunit pseudouridine synthase B (rluB) CSB-YP338071HTA
CSB-EP338071HTA
CSB-BP338071HTA
CSB-MP338071HTA
CSB-EP338071HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae HTH-type transcriptional regulator CysB (cysB) CSB-YP338072HTA
CSB-EP338072HTA
CSB-BP338072HTA
CSB-MP338072HTA
CSB-EP338072HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Phosphate acetyltransferase (pta), partial CSB-YP338073HTA
CSB-EP338073HTA
CSB-BP338073HTA
CSB-MP338073HTA
CSB-EP338073HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達載體可使外源基因在宿主細胞中高效表達,經(jīng)過多年的發(fā)展,表達載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務,您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>